Dr Stuart Frey, PHARM D in Forney, TEXAS - Pharmacist

Dr Stuart Frey, PHARM D is a Pharmacist based in Forney, TEXAS. Dr Stuart Frey is licensed to practice in Texas (license number 39999) and his current practice location is 802 East Us Hwy 80, Forney, Forney, TEXAS. He can be reached at his office (for appointments etc.) via phone at (972) 564-9160.

NPI number for Dr Stuart Frey is 1083215339 and his current mailing address is 10250 Richard Cir, Forney, Texas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1083215339.

Contact Information

	Dr Stuart Frey, PHARM D
	802 East Us Hwy 80, Forney, Forney, TEXAS 75126
	(972) 564-9160
	Not Available

Healthcare Provider's Profile

Full Name	Dr Stuart Frey
Gender	Male
Speciality	Pharmacist
Location	802 East Us Hwy 80, Forney, TEXAS
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1083215339
Provider Enumeration Date: 11/03/2020
Last Update Date: 10/28/2022

Medical Identifiers

Medical identifiers for Dr Stuart Frey such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1083215339	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	39999 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Stuart Frey is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Stuart Frey, PHARM D 10250 Richard Cir, Forney, TX 75126-7660 Ph: (469) 223-3446	Dr Stuart Frey, PHARM D 802 East Us Hwy 80, Forney, Forney, TEXAS 75126 Ph: (972) 564-9160

News Archive

Alternate primers for whole-genome SARS-CoV-2 sequencing

A new study published on the preprint server bioRxiv* in October 2020 describes the gap frequencies and positions in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome and a set of alternative primers with a sequencing scheme to provide better genomic coverage and quality.

Atomic layer deposition technique for incorporating "biological functionality" into complex nanomaterials

A team led by researchers from North Carolina State University has published a paper that describes the use of a technique called atomic layer deposition to incorporate "biological functionality" into complex nanomaterials, which could lead to a new generation of medical and environmental health applications. For example, the researchers show how the technology can be used to develop effective, low-cost water purification devices that could be used in developing countries.

Colorectal cancer and preventative screening legislation in the US

Even though colorectal cancer is one of the most preventable types of cancer, only 18 US states have enacted legislation requiring insurance providers to cover the cost of preventative screening. These findings from the 2004 Colorectal Cancer Legislation Report Card were released today by the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance (EIF's NCCRA) and the American Gastroenterological Association (AGA).

Research pinpoints new therapeutic opportunity for ovarian clear cell carcinomas

Mutations in the ARID1A gene are present in more than 50% of ovarian clear cell carcinomas (OCCC), for which effective treatments are lacking. Scientists at The Wistar Institute discovered that loss of ARID1A function enhances a cellular stress response pathway that promotes survival of cancer cells, which become sensitive to pharmacological inhibition of this pathway. These findings were published online in Cancer Research, a journal of the American Association for Cancer Research, and point to a new therapeutic opportunity for this type of ovarian cancer for which new solutions are urgently needed.

Dr Stuart Frey, PHARM D - Pharmacist in Forney, TEXAS